Early onset epilepsy can usually be better controlled or even cured if the triggers that cause epilepsy can be effectively controlled. Epilepsy is often associated with factors such as genetics, infection, or craniosynostosis. So treatment for epilepsy depends on the cause of its triggers and how well the patient responds to medications. Some patients with epilepsy can be cured, and some patients with epilepsy can control their seizures with medication, but a small number have intractable epilepsy that is difficult to control even after treatment. When seizures are caused by infection, the inflammation can gradually subside and the seizures will improve or even be cured after the causative organism is clarified and treated with adequate amounts of sensitive antibiotics. Epilepsy can also be secondary to intracranial organic diseases, mainly acquired cranial brain injuries, such as cerebrovascular disease, cranial trauma, brain tumors, cerebral parasitic diseases, demyelinating diseases, etc. Early active treatment for the primary disease can reduce the number of seizures. Some epilepsies may not have a clear cause and can be treated with antiepileptic drugs, which may also lead to clinical cure. When epilepsy is diagnosed, if there are only 1-2 seizures in 1 year, it can be temporarily observed and does not necessarily require medication. If there are more than 2 seizures in a year, the disease should be controlled with medication, which usually needs to be taken for a period of 3-5 years. The criteria for clinical cure are no seizures after control with medication, and repeated EEGs during medication, no signs of seizures, at least up to 2-3 years, then it means epilepsy is cured, then the medication can be gradually reduced, and the process of medication reduction should also be observed for recurrence, and then gradually transition to discontinuation of medication. If the epilepsy cannot be controlled even after the application of standardized drug treatment, with frequent seizures, up to 2-4 times per month, it is considered refractory epilepsy.